|
|
|
Painreform Ltd (NASDAQ: PRFX) |
|
PRFX's Market share relative to its competitors, as of Q4 2024
As of Q4 2024 (Revenue in Millions of $)
Date modified: 2025-06-14T12:59:50+00:00
|
Select the Relationship:
|
|
Select the Category:
|
|
PRFX's Market share relative to its competitors, as of Q4 2024 within the Major Pharmaceutical Preparations Industry
As of Q4 2024
| COMPANY NAME |
MARKET SHARE
12 Months Ending
Q4 2024 |
MARKET SHARE
12 Months Ending
Q3 2024 |
MARKET SHARE
MRQ
Q4 2024 |
MARKET SHARE
Q3 2024 |
| Painreform Ltd |
0.00% |
0.00% |
0.00 % |
0.00 % |
|
Elite Pharmaceuticals Inc
|
98.22%
|
98.24%
|
100.00%
|
100.00%
|
|
Baudax Bio Inc
|
1.78%
|
1.76%
|
0.00%
|
0.00%
|
| SUBTOTAL |
100% |
100% |
100% |
100% |
PRFX's Market share relative to its competitors, as of Q4 2024 within the Healthcare Sector
As of Q4 2024
Note: Market share is calculated based on total revenue. To get a more accurate picture of Painreform Ltd's market divisions, geographic dispersion, segments, products, and services, visit Painreform Ltd's Business Segment. The list includes publicly traded companies only. More information about the sources of this report can be found here. |
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
